California lawsuit accuses drugmakers of insulin overcharging
By Brendan Pierson (Reuters) -California is suing the United States’ leading insulin makers and pharmacy benefit managers, accusing them of using their market power to overcharge patients for the life-saving drug, the state’s attorney general announced on Thursday. The lawsuit, filed in California Superior Court in Los Angeles, targets Eli Lilly and Co, Novo Nordisk …
California lawsuit accuses drugmakers of insulin overcharging Read More »